Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20068162)

  • 1. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.
    Schaaf G; Hamdi M; Zwijnenburg D; Lakeman A; Geerts D; Versteeg R; Kool M
    Cancer Res; 2010 Jan; 70(2):762-71. PubMed ID: 20068162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer.
    Lo TL; Yusoff P; Fong CW; Guo K; McCaw BJ; Phillips WA; Yang H; Wong ES; Leong HF; Zeng Q; Putti TC; Guy GR
    Cancer Res; 2004 Sep; 64(17):6127-36. PubMed ID: 15342396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
    Kouraklis G; Triche TJ; Wesley R; Tsokos M
    Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
    Hanafusa H; Torii S; Yasunaga T; Nishida E
    Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glutathione-S-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma.
    Seitz G; Bonin M; Fuchs J; Poths S; Ruck P; Warmann SW; Armeanu-Ebinger S
    Int J Oncol; 2010 Feb; 36(2):491-500. PubMed ID: 20043085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
    Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation.
    Gastaldi T; Bonvini P; Sartori F; Marrone A; Iolascon A; Rosolen A
    Carcinogenesis; 2006 Sep; 27(9):1758-67. PubMed ID: 16537559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC inhibits ERK pathway activation and cellular proliferation induced by RAS.
    Park KS; Jeon SH; Kim SE; Bahk YY; Holmen SL; Williams BO; Chung KC; Surh YJ; Choi KY
    J Cell Sci; 2006 Mar; 119(Pt 5):819-27. PubMed ID: 16478791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
    Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
    Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H; Wierenga AT; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
    Céspedes MV; Sancho FJ; Guerrero S; Parreño M; Casanova I; Pavón MA; Marcuello E; Trias M; Cascante M; Capellà G; Mangues R
    Carcinogenesis; 2006 Nov; 27(11):2190-200. PubMed ID: 16679305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.
    Long IS; Han K; Li M; Shirasawa S; Sasazuki T; Johnston M; Tsao MS
    Mol Cancer Res; 2003 Mar; 1(5):393-401. PubMed ID: 12651912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
    Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
    Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.